Ever Supreme Bio Technology Co., Ltd (TPEX:6712)

TPEX:6712 Revenue

Ever Supreme Bio Technology had revenue of 190.49M TWD in the quarter ending March 31, 2026, with 7.06% growth. This brings the company's revenue in the last twelve months to 1.03B, up 8.61% year-over-year. In the year 2025, Ever Supreme Bio Technology had annual revenue of 1.02B with 8.96% growth.

• Revenue (ttm): 1.03B
• Revenue Growth: +8.61%
• P/S Ratio: 13.73
• Revenue / Employee: n/a
• Employees: 94
• Market Cap: 14.15B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.02B	83.69M	8.96%
Dec 31, 2024	933.81M	175.42M	23.13%
Dec 31, 2023	758.39M	130.88M	20.86%
Dec 31, 2022	627.51M	188.67M	42.99%
Dec 31, 2021	438.84M	368.24M	521.61%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 15, 2026

Data Sources Report a data error